These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
185 related articles for article (PubMed ID: 38726009)
1. Editorial: Analysis of tumor immune microenvironments and molecular mechanism to reveal the dilemma of immunotherapy for advanced non-small cell lung cancer. Roviello G; Vascotto IA; Catalano M Front Immunol; 2024; 15():1415608. PubMed ID: 38726009 [No Abstract] [Full Text] [Related]
3. Chemotherapy-induced immunomodulation in non-small-cell lung cancer: a rationale for combination chemoimmunotherapy. Zheng H; Zeltsman M; Zauderer MG; Eguchi T; Vaghjiani RG; Adusumilli PS Immunotherapy; 2017 Sep; 9(11):913-927. PubMed ID: 29338609 [TBL] [Abstract][Full Text] [Related]
4. Molecular basis and rationale for combining immune checkpoint inhibitors with chemotherapy in non-small cell lung cancer. Leonetti A; Wever B; Mazzaschi G; Assaraf YG; Rolfo C; Quaini F; Tiseo M; Giovannetti E Drug Resist Updat; 2019 Sep; 46():100644. PubMed ID: 31585395 [TBL] [Abstract][Full Text] [Related]
5. Mechanisms of resistance to targeted therapy and immunotherapy in non-small cell lung cancer: promising strategies to overcoming challenges. Xiang Y; Liu X; Wang Y; Zheng D; Meng Q; Jiang L; Yang S; Zhang S; Zhang X; Liu Y; Wang B Front Immunol; 2024; 15():1366260. PubMed ID: 38655260 [TBL] [Abstract][Full Text] [Related]
6. [Immunotherapy in non-small cell lung cancer patients: back to the future.]. Roberto M; Botticelli A; Cecere F; Cognetti F; Giusti R; Gelibter A; Lugini A; Nelli F; Nuti M; Santini D; Marchetti P Recenti Prog Med; 2019 Dec; 110(12):587-593. PubMed ID: 31909761 [TBL] [Abstract][Full Text] [Related]
7. Immunotherapy in the treatment of non-small cell lung cancer. Bílek O; Bořilová S; Grell P; Kiss I Klin Onkol; 2021; 34(Supplementum 1):54-64. PubMed ID: 34154331 [TBL] [Abstract][Full Text] [Related]
8. Targeting Immunometabolism Mediated by CD73 Pathway in Passarelli A; Aieta M; Sgambato A; Gridelli C Front Immunol; 2020; 11():1479. PubMed ID: 32760402 [TBL] [Abstract][Full Text] [Related]
9. [Predictive biomarkers for immune checkpoint inhibitors in non-small-cell lung cancer]. Fu MJ; Zhou JY Zhonghua Jie He He Hu Xi Za Zhi; 2020 Feb; 43(2):87-91. PubMed ID: 32062877 [TBL] [Abstract][Full Text] [Related]
10. Machine learning reveals a PD-L1-independent prediction of response to immunotherapy of non-small cell lung cancer by gene expression context. Wiesweg M; Mairinger F; Reis H; Goetz M; Kollmeier J; Misch D; Stephan-Falkenau S; Mairinger T; Walter RFH; Hager T; Metzenmacher M; Eberhardt WEE; Zaun G; Köster J; Stuschke M; Aigner C; Darwiche K; Schmid KW; Rahmann S; Schuler M Eur J Cancer; 2020 Nov; 140():76-85. PubMed ID: 33059196 [TBL] [Abstract][Full Text] [Related]
11. The use of combination immunotherapies as front-line therapy for non-small-cell lung cancer. Santana-Davila R; Chow LQ Future Oncol; 2018 Feb; 14(3):191-194. PubMed ID: 29334785 [No Abstract] [Full Text] [Related]
12. Active specific immunotherapy and cell-transfer therapy for the treatment of non-small cell lung cancer. Kakimi K; Nakajima J; Wada H Lung Cancer; 2009 Jul; 65(1):1-8. PubMed ID: 19062127 [TBL] [Abstract][Full Text] [Related]
13. Interleukin-33, a Potential Cytokine Expressed in Tumor Microenvironment Involves in Antitumor Immunotherapy Through Facilitates CD8 Li X; Lv Q; Feng Y; Gu Y; Xia R; Ma J; He H; Zhu Y J Interferon Cytokine Res; 2018 Nov; 38(11):491-499. PubMed ID: 30452317 [TBL] [Abstract][Full Text] [Related]
14. [Promise of Neoadjuvant Immunotherapy in Resected Non-small Cell Lung Cancer]. Yao S; Zhang Y Zhongguo Fei Ai Za Zhi; 2020 Jan; 23(1):55-59. PubMed ID: 31948539 [TBL] [Abstract][Full Text] [Related]
15. To Treat or Not to Treat: Role of Immunotherapy in Patients with Concomitant Diagnosis of Advanced-Stage Non-Small Cell Lung Cancer and Psoriasis. Khunger M; Calabrese C; Kontzias A; Velcheti V J Thorac Oncol; 2017 Sep; 12(9):e147-e149. PubMed ID: 28838717 [No Abstract] [Full Text] [Related]
19. Immunotherapy for non-small cell lung cancers: biomarkers for predicting responses and strategies to overcome resistance. Pu X; Wu L; Su D; Mao W; Fang B BMC Cancer; 2018 Nov; 18(1):1082. PubMed ID: 30409126 [TBL] [Abstract][Full Text] [Related]
20. Evaluation of TMB as a predictive biomarker in patients with solid cancers treated with anti-PD-1/CTLA-4 combination immunotherapy. Klein O; Kee D; Markman B; Carlino MS; Underhill C; Palmer J; Power D; Cebon J; Behren A Cancer Cell; 2021 May; 39(5):592-593. PubMed ID: 33930312 [No Abstract] [Full Text] [Related] [Next] [New Search]